Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,119 hedge funds and large institutions have $92.6B invested in Allergan plc in 2016 Q1 according to their latest regulatory filings, with 122 funds opening new positions, 427 increasing their positions, 439 reducing their positions, and 97 closing their positions.
26% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 97
1% more funds holding
Funds holding: 1,110 → 1,119 (+9)
3% less repeat investments, than reductions
Existing positions increased: 427 | Existing positions reduced: 439
14% less funds holding in top 10
Funds holding in top 10: 181 → 155 (-26)
15% less capital invested
Capital invested by funds: $109B → $92.6B (-$16.6B)
39% less call options, than puts
Call options by funds: $3.05B | Put options by funds: $5.02B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$512M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$493M |
| 3 |
D.E. Shaw & Co
New York
|
+$397M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$300M |
| 5 |
Goldman Sachs
New York
|
+$293M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$561M |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
-$417M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$314M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$261M |
| 5 |
Coatue Management
New York
|
-$257M |
AGN Hedge Fund Activity: Q1 2016 in Review
1,119 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2016, worth a combined $92.6B — down 15% from $109B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new AGN positions and 97 closed out — a net gain of 25 holders — while 427 added to existing stakes and 439 trimmed.
The largest buyer was Lone Pine Capital, opening a new position worth an estimated $512M. The largest seller was Fidelity Investments, cutting an estimated $561M.
- 1,119 institutional investors held Allergan plc (AGN) as of Q1 2016, up from 1,110 in Q4 2015.
- Funds reported $92.6B of Allergan plc stock for Q1 2016, down 15% quarter-over-quarter.
- 122 funds opened new Allergan plc positions in Q1 2016 and 97 closed out, a net change of +25 holders.
- The largest Allergan plc buyer in Q1 2016 was Lone Pine Capital, an estimated $512M added.
- The largest Allergan plc seller in Q1 2016 was Fidelity Investments, an estimated $561M sold.
Based on aggregated 13F filings for Q1 2016.